Related Experiment Video

Updated: Jun 3, 2026

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
08:04

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

The novel benzimidazole derivative, MPTB, induces cell apoptosis in human chondrosarcoma cells

Te-Mao Li1, Tsang-Yu Lin, Sheng-Feng Hsu

  • 1School of Chinese Medicine, China Medical University, Taichung, Taiwan.

Molecular Carcinogenesis
|March 5, 2011
PubMed

Insights

A new compound, MPTB, effectively triggers cancer cell death in human chondrosarcoma. This benzimidazole derivative shows significant tumor reduction in animal models, offering a promising new avenue for chondrosarcoma treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Chondrosarcoma is a primary bone cancer with limited treatment options.
  • Chemotherapy and radiation therapy show poor efficacy against chondrosarcoma.
  • Novel therapeutic strategies are urgently needed for chondrosarcoma treatment.

Purpose of the Study:

  • To investigate the anti-cancer effects of a novel benzimidazole derivative, MPTB (5-methyl-2(pyridine-3-yl)-1-(3,4,5-trimethoxybenzyl)benzimidazole), on human chondrosarcoma cells.
  • To elucidate the molecular mechanisms underlying MPTB's anti-cancer activity.
  • To evaluate the efficacy of MPTB in a murine tumor model.

Main Methods:

  • MPTB treatment on human chondrosarcoma cell lines (JJ012, SW1353) and primary chondrocytes.
  • Assessment of apoptosis, mitochondrial dysfunction, endoplasmic reticulum (ER) stress, and calcium levels.
  • Analysis of Bax, Bak, glucose-regulated protein (GRP), and calpain expression.
  • RNA interference (siRNA) targeting GRP78 and calpain.
  • In vivo studies using a murine tumor model.

Main Results:

  • MPTB induced apoptosis in chondrosarcoma cells but not in primary chondrocytes.
  • MPTB upregulated pro-apoptotic proteins Bax and Bak, leading to mitochondrial dysfunction.
  • MPTB triggered ER stress, evidenced by altered calcium levels and increased GRP expression.
  • MPTB increased calpain expression; siRNA knockdown of GRP78 or calpain attenuated MPTB-induced apoptosis.
  • MPTB treatment resulted in a 44% reduction in tumor volume in mice over 21 days.

Conclusions:

  • MPTB exhibits significant anti-cancer activity against human chondrosarcoma cells.
  • MPTB-induced apoptosis involves mitochondrial dysfunction, ER stress, and calpain activation.
  • MPTB demonstrates therapeutic potential in preclinical chondrosarcoma models.
  • MPTB represents a promising novel therapeutic agent for chondrosarcoma.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...